Related Experiment Video
Updated: Jul 2, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Unaltered SNARE complex formation in an in vivo model of prion disease
Ayodeji A Asuni1, Colm Cunningham, Piranavhan Vigneswaran
1School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton, SO16 7PX, UK.
Abstract:
The ME7 model of prion disease is a chronic slowly evolving model of neurodegeneration in which cell death is preceded by synaptic dysfunction. Previous studies in cell culture show that accumulation of misfolded prion inhibits the formation of the SNARE complexes involving synaptobrevin, syntaxin and SNAP-25 that play an essential role in neurotransmitter release. Such observations suggest that similar phenomenon may contribute to synaptic dysfunction observed in vivo. We have thus used detergent extraction of hippocampal tissue to investigate the status of SNARE complexes in the ME7 model. In the presence of increasing PrP(Sc) deposition we failed to see a change in the amount of SNARE complexes directly extracted into SDS and resolved by SDS-PAGE. Conversely pre-extraction in Triton X-100, a treatment that promotes SNARE complexes ex vivo, demonstrated a modest reduction in hippocampal SNARE complexes when homogenates were made from tissue at late stage disease. This suggests that accumulated PrP(Sc), or perhaps fibrillar complexes formed of prion only inhibit SNARE complexes that are formed ex vivo following biochemical extraction. Thus the accumulation of PrP(Sc) although deleterious to synaptic function in vivo, does not exert its synaptic effects by disrupting the formation of SNARE complexes that are core to transmitter release.
Insights
Prion disease (PrPSc) accumulation impairs synaptic function but does not disrupt SNARE complex formation essential for neurotransmitter release in the ME7 mouse model. This finding clarifies the mechanism of neurodegeneration in prion diseases.
Area of Science:
- Neuroscience
- Prion Biology
- Molecular Neurodegeneration
Background:
- Prion diseases cause chronic neurodegeneration, characterized by synaptic dysfunction preceding neuronal death.
- Misfolded prion protein (PrPSc) accumulation is implicated in synaptic dysfunction.
- SNARE complexes, crucial for neurotransmitter release, are potentially inhibited by PrPSc.
Purpose of the Study:
- To investigate the impact of PrPSc deposition on SNARE complex integrity in the ME7 mouse model of prion disease.
- To determine if PrPSc disrupts SNARE complex formation in vivo, contributing to synaptic dysfunction.
Main Methods:
- Biochemical analysis of hippocampal tissue from the ME7 prion disease model.
- Detergent extraction (SDS and Triton X-100) to isolate SNARE complexes.
- SDS-PAGE to quantify SNARE complex levels.
Main Results:
- No change in directly SDS-extracted SNARE complexes with increasing PrPSc deposition.
- A modest reduction in Triton X-100 pre-extracted SNARE complexes at late stages of disease.
- PrPSc accumulation does not disrupt the formation of core SNARE complexes.
Conclusions:
- Accumulated PrPSc in the ME7 model does not inhibit the formation of essential SNARE complexes.
- The synaptic dysfunction observed in prion disease is not caused by PrPSc disrupting SNARE complex formation.
- PrPSc may inhibit ex vivo formed SNARE complexes, but not the in vivo essential machinery.
More Related Videos
10:26Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Published on: March 12, 2018
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
SNAREs and Membrane Fusion
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...